Australia markets closed

Botanix Pharmaceuticals Limited (BOT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.05600.0000 (0.00%)
At close: 03:39PM AEDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Operating expenses
Research development
10,293
10,293
6,571
13,699
16,630
Selling general and administrative
3,556
3,556
2,244
8,252
3,189
Total operating expenses
15,941
15,941
10,267
24,259
21,459
Operating income or loss
-15,941
-15,941
-10,267
-24,259
-21,459
Interest expense
37.44
37.44
55.941
50.982
11.206
Total other income/expenses net
2,770
2,770
6,885
7,399
4,306
Income before tax
-13,171
-13,171
-3,334
-16,731
-17,039
Income tax expense
0
0
0
0
0
Income from continuing operations
-13,171
-13,171
-3,334
-16,731
-17,039
Net income
-13,171
-13,171
-3,334
-16,731
-17,039
Net income available to common shareholders
-13,171
-13,171
-3,334
-16,731
-17,039
Basic EPS
-
-
-0.00
-0.02
-0.02
Diluted EPS
-
-
-0.00
-0.02
-0.02
Basic average shares
-
-
972,935
936,371
760,484
Diluted average shares
-
-
972,935
936,371
760,484
EBITDA
-
-12,990
-3,184
-16,577
-17,026